Policy Lessons From Medical Responses to the COVID-19 Crisis

Abstract This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their political economy context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely or...

Full description

Saved in:
Bibliographic Details
Main Author: Giovanni Dosi
Format: Article
Language:English
Published: Springer 2021-12-01
Series:Intereconomics
Online Access:https://doi.org/10.1007/s10272-021-1009-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525620906917888
author Giovanni Dosi
author_facet Giovanni Dosi
author_sort Giovanni Dosi
collection DOAJ
description Abstract This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their political economy context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely originated in public or non-profit institutions. Second, symmetrically, there is longer-term evidence that the private sector (essentially big pharma) has decreased its investment in basic research in general and has long been uninterested in vaccines in particular. Only when flooded with an enormous amount of public money did it become eager to undertake applied research, production scale-up and testing. Third, the political economy of the underlying public-private relationship reveals a profound dysfunctionality with the public being unable to determine the rates and direction of innovation, but at the same time confined to the role of payer of first and last resort, with dire consequences for both advanced, and more so developing countries. Fourth, on normative grounds, measures like ad hoc patent waivers are certainly welcome, but this will not address the fundamental challenge, involving a deep reform of the intellectual property rights regimes and their international protection.
format Article
id doaj-art-604faa3970f741e8b8c6f4c4a619b1a6
institution Kabale University
issn 0020-5346
1613-964X
language English
publishDate 2021-12-01
publisher Springer
record_format Article
series Intereconomics
spelling doaj-art-604faa3970f741e8b8c6f4c4a619b1a62025-01-17T08:34:14ZengSpringerIntereconomics0020-53461613-964X2021-12-0156633734010.1007/s10272-021-1009-2Policy Lessons From Medical Responses to the COVID-19 CrisisGiovanni Dosi0Institute of Economics, Scuola Superiore Sant’AnnaAbstract This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their political economy context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely originated in public or non-profit institutions. Second, symmetrically, there is longer-term evidence that the private sector (essentially big pharma) has decreased its investment in basic research in general and has long been uninterested in vaccines in particular. Only when flooded with an enormous amount of public money did it become eager to undertake applied research, production scale-up and testing. Third, the political economy of the underlying public-private relationship reveals a profound dysfunctionality with the public being unable to determine the rates and direction of innovation, but at the same time confined to the role of payer of first and last resort, with dire consequences for both advanced, and more so developing countries. Fourth, on normative grounds, measures like ad hoc patent waivers are certainly welcome, but this will not address the fundamental challenge, involving a deep reform of the intellectual property rights regimes and their international protection.https://doi.org/10.1007/s10272-021-1009-2
spellingShingle Giovanni Dosi
Policy Lessons From Medical Responses to the COVID-19 Crisis
Intereconomics
title Policy Lessons From Medical Responses to the COVID-19 Crisis
title_full Policy Lessons From Medical Responses to the COVID-19 Crisis
title_fullStr Policy Lessons From Medical Responses to the COVID-19 Crisis
title_full_unstemmed Policy Lessons From Medical Responses to the COVID-19 Crisis
title_short Policy Lessons From Medical Responses to the COVID-19 Crisis
title_sort policy lessons from medical responses to the covid 19 crisis
url https://doi.org/10.1007/s10272-021-1009-2
work_keys_str_mv AT giovannidosi policylessonsfrommedicalresponsestothecovid19crisis